HAL shares in focus after Rs 13,500 crore Su-30 MKI deal with Defence Ministry

Shares of Hindustan Aeronautics (HAL) on Friday (December 13) opened with a positive market reaction following its announcement of a Rs 13,500 crore deal with the Ministry of Defence for the procurement of 12 Su-30 MKI aircraft.

HAL Shares See Investor Interest

In response to this announcement, the company’s stock opened at Rs 4,754.50, reaching a high of Rs 4,755 during the early trading hours.

By 10:37 AM IST, the stock was trading at Rs 4,677.80, reflecting a gain of Rs 17.25 or 0.37 per cent.

A Major Defence Deal

HAL on December 12 has secured a contract with the Ministry of Defence for the procurement of 12 Su-30 MKI aircraft, valued at approximately Rs 13,500 crore, including taxes and duties.

Also Read: International Gemmological Institute Vs Inventurus Knowledge Solutions: Which IPO is better to apply?

“In a major boost to the Aatmanirbhar Bharat’ initiative of the government, a contract for procurement of 12 Su-30MKI aircraft along with associated equipment has been signed between Ministry of Defence and M/s Hindustan Aeronautics Limited (HAL) today on 12.12.2024, at an approximate cost of 13,500 Crore inclusive of taxes and duties,” added the company in the BSE filing.

As per the regulatory filing the company further noted, “The aircraft would have an indigenous content of 62.6%, enhanced due to indiginisation of many components to be manufactured by Indian defence industry.”

Key Financial Indicators and Stock Performance

As of the latest updates, HAL’s market capitalisation stands at Rs 3.13 lakh crore, with a price-to-earnings ratio of 36.73.

Moreover, the company has a dividend yield of 0.75 per cent. The company’s 52-week high stood at Rs 5,674.75, while its low was Rs 2,585.00.

HAL has seen an increase of Rs 74.35 or 1.61 per cent in its stock price over the past five days, bringing it to Rs 4,692.00.

 » Read More

Related Articles

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s

WazirX’s $235 million hack: Crypto exchange gets Singapore court nod to repay customer funds

Cryptocurrency exchange WazirX, owned by Singapore-based Zettai Pte Ltd, has received approval from the Singapore High Court to convene a scheme meeting with its users to repay them funds stolen in a $235 million hack in July last year. North Korean Lazarus group was found responsible for the cyberattack. A scheme meeting is a shareholders’

Markets rebound! Nifty over 23,200, Sensex up 230 points led by tech stocks

Indian equity indices opened Thursday’s trading session gap-down. The NSE Nifty 50 opened 35 points, or 0.15%, lower at 23,120.95, while the BSE Sensex fell 106 points, or 0.14%, to open at 76,298.96. Hindustan Unilever’s share price declined by 3%. However, both indices soon started to trade in the green. At 10 am around, the